HomeAnswersHematologyhemoglobinWhat causes increase in the level of hemoglobin?

Is it bad to have high level of hemoglobin?

Share

The following is an actual conversation between an iCliniq user and a doctor that has been reviewed and published as a Premium Q&A.

Medically reviewed by

iCliniq medical review team

Published At January 3, 2021
Reviewed AtJanuary 18, 2024

Patient's Query

Hi doctor,

My hematology report shows a hemoglobin of 18.8 g/dL, hematocrit of 54.0 % and mean corpuscular hemoglobin concentration of 34.7 g/dL, and red cell distribution width of 19.3 % (all are high). The other parameters such as RBC and WBC are found normal. I have a comment on the morphology of RBC as predominantly normocytic normochromic with mild anisocytosis. The WBC shows normal morphology and platelets are adequate. Does having a high level of hemoglobin is bad and what is the cause behind it?

Hi,

Welcome to icliniq.com.

You have a condition showing an increased level of hemoglobin. Elevated hemoglobin is seen in smokers, in people living at high altitudes, congestive cardiac failure, chronic obstructive pulmonary disease, some erythropoietin secreting adenomas of a kidney, and very rarely it could be a part of primary polycythemia. It is necessary to rule out the causes of secondary polycythemia. If all the causes are excluded, you need to Get JAK2 (Janus kinase 2), Exon12, and CALR (calreticulin) mutations tested.

Even in primary polycythemia also called polycythemia rubra vera, these mutations are negative frequently. In primary polycythemia, if JAK2 is negative, then the treatment is therapeutic phlebotomy or venesection. The goal is to keep hemoglobin and hematocrit within the range and for the males, it should be less than 50 percent and for a female, it should be less than 48 percent.

The hemoglobin level has to be 16 mg/dL for males and then it should be 15 g/dL for females. It can be combined with hydroxyurea and the dose is calculated according to the weight of the patient. Repeated venesections or phlebotomies can lead to micronutrient deficiency especially iron. The patient should be given micronutrient replacement therapy.

For JAK2 positive patients, tablet Ruxolitinib is given in a dose of 5 to 15 mg per day. Another option is IFN (interferon) alpha in a low dose of 45 ugs per week in both JAK2 positive or negative cases. CALR positive cases show superior results in this mode. It takes a few years to cure the disease. Meanwhile, along with all the therapeutic modalities, thrombophilia prophylaxis is given. This is not a life-threatening disease.

Same symptoms don't mean you have the same problem. Consult a doctor now!

Dr. Mubashir Razzaq Khan
Dr. Mubashir Razzaq Khan

Hematology

Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Read answers about:

hemoglobinpolycythemia vera

Ask your health query to a doctor online

Hematology

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy